United Kingdom Anthrax Treatment Market Size & Outlook, 2025-2033


United Kingdom Anthrax Treatment Market Insights

  • As highlighted in Reed Intelligence analysis, the United Kingdom Anthrax Treatment Market, worth USD 19.34 Million in 2024, is forecasted to achieve USD 32.29 Million by 2033.
  • The United Kingdom market is anticipated to grow at a CAGR of 5.84% during the period 2026–2033.
  • By 2024, Cutaneous Anthrax represented the largest share of the By Disease Type market size.
  • Inhalation Anthrax is expected to remain the key growth driver within By Disease Type, registering the fastest CAGR during the forecast period.

Other Key Findings


  • As of 2024, United Kingdom held 4.58% of the global Anthrax Treatment Market size.
  • By 2033, United States is anticipated to capture the largest share of the global Anthrax Treatment Market.
  • In Europe, Germany is expected to lead the regional Anthrax Treatment Market size by 2033.
  • Nordic will remain the fastest-growing market in Europe, reaching USD 8.43 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 19.34 Million
Market Size In 2033 USD 32.29 Million
Largest segment Cutaneous Anthrax
Units Revenue in USD Million
CAGR 5.84% (2025-2033)
Segmnetation Covered
By Disease Type
  1. Cutaneous Anthrax
  2. Inhalation Anthrax
  3. Gastrointestinal Anthrax
  4. Injection Anthrax
By Treatment Type
  1. Antibiotics
  2. Immunoglobulins
  3. Others
By Route of Administration
  1. Parenteral
  2. Oral
By End-User
  1. Hospitals
  2. Clinics
  3. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports